comparemela.com

Latest Breaking News On - Ton logtenberg - Page 1 : comparemela.com

SynOx Therapeutics secures $75m to fund tenosynovial giant cell tumor trial

SynOx Therapeutics has raised $75m in Series B financing, co-led by Forbion, HealthCap and new investor Bioqube Ventures.

Merus (NASDAQ:MRUS) Receives Average Rating of Moderate Buy from Brokerages

Shares of Merus (NASDAQ:MRUS – Get Rating) have earned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average 12 month price […]

Tekla Capital Management LLC Sells 76,882 Shares of Merus (NASDAQ:MRUS)

Tekla Capital Management LLC trimmed its position in shares of Merus (NASDAQ:MRUS – Get Rating) by 45.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 92,325 shares of the biotechnology company’s stock after selling 76,882 shares during the period. Tekla Capital […]

Merus (NASDAQ:MRUS) Receives Consensus Rating of Moderate Buy from Analysts

Shares of Merus (NASDAQ:MRUS – Get Rating) have been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and seven have assigned a buy recommendation to the company. The average 12 month target price […]

Merus (NASDAQ:MRUS) Receives $42 67 Average PT from Brokerages

Shares of Merus (NASDAQ:MRUS – Get Rating) have earned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and seven have given a buy recommendation to the company. The average 1 year price target […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.